Exeltis USA Dermatology

Exeltis USA Dermatology is a specialized division of Exeltis USA, the North American branch of the global pharmaceutical group Insud Pharma. The company focuses on the development and commercialization of branded prescription products for a variety of dermatological conditions. Its current portfolio includes treatments for acne vulgaris, plaque psoriasis, and various inflammatory or fungal skin disorders. Key commercial products include Ximino, an extended-release minocycline, and Impoyz, a high-potency corticosteroid cream. The division leverages the extensive global R&D and manufacturing capabilities of its parent company to bring cost-effective therapeutic options to the US market. Headquartered in Florham Park, New Jersey, Exeltis USA Dermatology maintains a strong field presence to support healthcare providers and patients.